Diagnostic and predictive values of CYFRA 21 - 1 and CEA in patients with non - small cell lung cancer

Downloads

Download data is not yet available.
PDF (Tiếng Việt)     2    1

Abstract

Purpose: To evaluate the diagnostic and predictive values of high preoperative CYFRA 21 - 1 and CEA serum levels in patients with stage I - IIIA non - small cell lung cancer (NSCLC).

Methods: Medical records of patients with NSCL Coperated in two years 2018 - 2019 at Surgery Department No 2, HCMC Oncology Hospital were studied retrospectively.

Results: Preoperative CYFRA 21 - 1 serum levels correlated well wih the disease stage (p = 0,011), but high preoperative CYFRA 21 - 1 serum level (> 3.3 ng/mL) may not predict well the patients with NSCLC being in advanced clinical stages. Preoperative CEA serum levelswere not good indicators to predict the disease stage. Combination of high preoperative CYFRA 21 - 1 (> 3.3 ng/mL) and CEA (> 5ng/mL) serum levelsin patients with suspected NSCLC may suggest that the histologic result of their tumors was adenocarcinoma.

Conclusion: Preoperative CYFRA 21 - 1 and CEA serum levels were not good indicators to predict the disease stage. Combination of high preoperative CYFRA 21 - 1 (> 3.3 ng/mL) and CEA (> 5ng/mL) serum levels in patients with suspected NSCLC may suggest that the histologic result of their tumors was adenocarcinoma.

https://doi.org/10.38103/jcmhch.82.8

References

Globocan 2020. Available at: URL: https://gco.iarc.fr/today/ data/factsheets populations/704-viet-nam-fact-sheets.pdf

Phạm Xuân Dũng, Đặng Huy Quốc Thịnh, Bùi Đức Tùng, Quách Thanh Khánh và ctv. Kết quả ghi nhận ung thư quần thể thành phố Hồ Chí Minh 2016.Tạp chí Ung thư học Việt Nam 2019; 5:23- 29.

Perkins GL, Slater ED, Sanders GK, Prichard JG. Serum Tumor Markers. Am Fam Physician. 2003;68:1075-82.

Grunnet M., Sorensen J.B. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138-143.

Liu L, Teng J, Zhang L, Cong P et al. The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer. Biomed Res Int2017;2017:2013989.

Molina R, Marrades RM, Augé JM, Escudero JM et al. Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer. Am J Respir Crit Care Med2016;193(4):427-437.

Okamura K, Takayama K, Izumi M, Harada T et al. Diagnostic value of CEA and CYFRA 21 - 1 tumor markers in primary lung cancer. Lung Cancer. 2013;80(1):45-49.

Rami - Porta R et al. Lung. In: Amin M.B. (Editor - in - Chief) AJCC Cancer Staging Manual. 8th edition. Springer. 2017: 431-456.

Duma N, Santana-Davila R, Molina JR. Non - small cell lung cancer: Epidemiology, Sreenning, Diagnosis and Treatment. Mayo Clin Proc. 2019; 94(8):1623-1640.

Wieskopf B, Demangeat C, Purohit A, Stenger R et al. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. Chest. 1995;108(1):163-169.

Duffy MJ et al. Clinical Utility of Biochemical Markers in Colorectal Cancer: European Group on Tumour Markers Guidelines. Eur J Cancer.2003; 39:718-727.

Duffy MJ. Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful ? Clin Chemistry. 2001; 47(4): 624-630.

Ordonez C et al. Human Carcinoembryonic Antigen Function as a General Inhibitor of Anoikis. Cancer Research. 2000; 60:3419-3424.

Chen F, Li J, Qi X, Qi J.Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease. J Cancer Res Ther. 2018; 14(Suppl):S400-S404.

Watine J, Friedberg B. Preoperative Carcinoembryonic Antigen Level as an Independent Prognostic Factor in Colon Cancer. Further Comments. Jpn J Clin Oncol.2000; 30(1):522.

Postmus PE, Kerr KM, Oudkerk M, Senan S et al. ESMO Guidelines Committee. Early and locally advanced non- small - cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017; 28(suppl_4): iv1-iv21.

Ettinger DS et al. Non - Small Cell Lung Cancer, version 4.2021, NCCN Clinical Practice Guidelines in Oncology. Available from: URL: https://www.nccn.org/professionals/ physician_gls/pdf/nscl.pdf

Published 26-07-2022
Fulltext
PDF (Tiếng Việt)     2    1
Language
Issue No. 82 (2022)
Section Original article
DOI 10.38103/jcmhch.82.8
Keywords Ung thư phổi không tế bào nhỏ, CYFRA 21 - 1, CEA, giá trị chẩn đoán, giá trị tiên lượng Non - small cell lung cancer, CYFRA 21 - 1, CEA, diagnostic value, predictive value

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Journal of Clinical Medicine Hue Central Hospital

Huu, H., & Cuong, P. H. (2022). Diagnostic and predictive values of CYFRA 21 - 1 and CEA in patients with non - small cell lung cancer. Journal of Clinical Medicine Hue Central Hospital, (82), 52–57. https://doi.org/10.38103/jcmhch.82.8